Long-term outcomes of adults with first-relapsed/refractory systemic anaplastic large-cell lymphoma in the pre-brentuximab vedotin era: A LYSA/SFGM-TC study - ENS de Lyon - École normale supérieure de Lyon Accéder directement au contenu
Article Dans Une Revue European Journal of Cancer Année : 2017

Long-term outcomes of adults with first-relapsed/refractory systemic anaplastic large-cell lymphoma in the pre-brentuximab vedotin era: A LYSA/SFGM-TC study

Domaines

Hématologie
Fichier non déposé

Dates et versions

hal-01655967 , version 1 (05-12-2017)

Identifiants

Citer

Alexandre Morel, Josette Brière, Laurence Lamant, Michael Loschi, Corinne Haioun, et al.. Long-term outcomes of adults with first-relapsed/refractory systemic anaplastic large-cell lymphoma in the pre-brentuximab vedotin era: A LYSA/SFGM-TC study. European Journal of Cancer, 2017, 83, pp.146 - 153. ⟨10.1016/j.ejca.2017.06.026⟩. ⟨hal-01655967⟩
180 Consultations
0 Téléchargements

Altmetric

Partager

Gmail Facebook X LinkedIn More